SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet 2020 Jan 30]. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• WHO. Coronavirus disease (COVID-19) outbreak; 2020 [cited 2020 Sept 03]. Available from: https://www.who.int.
   Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027–1031.
   PubMed Web of Science ®Google Scholar
• Picchianti Diamanti A, Rosado MM, Pioli C, et al. Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity. Int J Mol Sci. 2020;21(9):3330.
   Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[ published correction appears in Lancet Respir Med. 2020 Feb 25]. Lancet Respir Med. 2020;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451–2460.
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474.
   PubMed Web of Science ®Google Scholar
• Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5(5):794–799.
   PubMed Web of Science ®Google Scholar
• Tisoncik JR, Korth MJ, Simmons CP, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16–32.
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–724.
   PubMed Web of Science ®Google Scholar
• Coperchini F, Chiovato L, Croce L, et al. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32.
   PubMed Web of Science ®Google Scholar
• Croce L, Gangemi D, Ancona G, et al., The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest. 44(1): 1–14. 2021.
   PubMedGoogle Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages [published correction appears in Nat Rev Immunol. 2020 Jun 2]. Nat Rev Immunol. 2020;20(6):355–362.
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.
   PubMed Web of Science ®Google Scholar
• Hue S, Beldi-Ferchiou A, Bendib I, et al. Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;202(11):1509–1519.
   PubMed Web of Science ®Google Scholar
• De Biasi S, Meschiari M, Gibellini L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11(1):3434.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Zhang D, et al. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1708.
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Giuffrida G, Campennì A. Autoimmune endocrine diseases. Minerva Endocrinol. 2018;43(3):305–322.
   PubMed Web of Science ®Google Scholar
• Minciullo PL, Ruggeri RM, Vita G, et al. Development of Hashimoto’s thyroiditis after subacute thyroiditis: an unusual patient. Thyroid. 2009;19(1):73–74.
   PubMed Web of Science ®Google Scholar
• Nanba T, Watanabe M, Inoue N, et al. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 2009;19(5):495–501.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang H, Su Z, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand J Immunol. 2010;72(3):250–255.
   PubMed Web of Science ®Google Scholar
• Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953–962.
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto’s thyroiditis. Endocr J. 2014;61(4):359–363.
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Minciullo P, Saitta S, et al. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto’s thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones (Athens). 2014;13(3):338–344.
   PubMedGoogle Scholar
• Vitales-Noyola M, Ramos-Levi AM, Martínez-Hernández R, et al. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine. 2017;57(3):409–417.
   PubMed Web of Science ®Google Scholar
• Kristensen B, Hegedüs L, Madsen HO, et al. Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto’s thyroiditis. Clin Exp Immunol. 2015;180(1):58–69.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang B, Mu K, et al. The pathogenesis of thyroid autoimmune diseases: new T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm. J Cell Physiol. 2019;234(3):2204–2216.
   PubMed Web of Science ®Google Scholar
• Mazziotti G, Sorvillo F, Piscopo M, et al. Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study. J Clin Endocrinol Metab. 2005;90(7):4138–4144.
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Campennì A, Giuffrida G, et al. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). J Endocrinol Invest. 2019;42(7):745–756.
   PubMed Web of Science ®Google Scholar
• Scappaticcio L, Castellana M, Virili C, et al. Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest. 2020;43(2):219–229.
   PubMed Web of Science ®Google Scholar
• Carella C, Mazziotti G, Amato G, et al. Clinical review 169: interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab. 2004;89(8):3656–3661.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Brogioni S, Grasso L, et al. Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab. 1994;79(5):1424–1427.
   PubMed Web of Science ®Google Scholar
• Trovato M, Ruggeri RM, Sciacchitano S, et al. Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up. Immunobiology. 2018;223(3):264–268.
   PubMed Web of Science ®Google Scholar
• Van Den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456–1465.
   PubMed Web of Science ®Google Scholar
• Moutchia J, Pokharel P, Kerri A, et al. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS One. 2020;15(10):e0239802.
   PubMed Web of Science ®Google Scholar
• Zou R, Wu C, Zhang S, et al. Euthyroid sick syndrome in patients with COVID-19. Front Endocrinol (Lausanne). 2020;11:566439.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Bogazzi F, Brogioni S, et al. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138:603–614.
   PubMed Web of Science ®Google Scholar
• Farwell AP. The thyroid: a fundamental and clinical text. Philadelphia (PA): Wolters Kluwer; 2013.
   Google Scholar
• Ohsako N, Tamai H, Sudo T, et al. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab. 1995;80(12):3653–3656.
   PubMed Web of Science ®Google Scholar
• Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6(1):5.
   PubMedGoogle Scholar
• Pearce EN, Farwell AP, Braverman LE. Thyroiditis [published correction appears in N Engl J Med. 2003 Aug 7; 349:620]. N Engl J Med. 2003;348:(26):2646–2655.
   PubMed Web of Science ®Google Scholar
• Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020;43(8):1171–1172.
   PubMed Web of Science ®Google Scholar
• Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020;43(8):1173–1174.
   PubMed Web of Science ®Google Scholar
• San MillánB R, Tantinyà Daura M, Hurtado Ganoza A, et al. Painless thyroiditis in SARS-CoV-2 infection. Endocrinol Diabetes Nutr. 2020;S2530–0164(20)30203–2.
   Google Scholar
• Mathews SE, Castellanos-Diaz J, Srihari A, et al. Subacute thyroiditis and heart failure in a patient presenting with COVID-19. J Investig Med High Impact Case Rep. 2021;9:23247096211009412.
   Web of Science ®Google Scholar
• Davoodi L, Oladi Z, Jafarpour H, et al. A 33-year-old man with COVID-19 presented with subacute thyroiditis: a rare case report and literature review. New Microbes New Infect. 2021;41:100871.
   PubMed Web of Science ®Google Scholar
• Brancatella A, Ricci D, Viola N, et al. Subacute thyroiditis after Sars-COV-2 infection. J Clin Endocrinol Metab. 2020;105(7):dga a276.
   Web of Science ®Google Scholar
• Ruggeri RM, Campennì A, Siracusa M, et al. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens). 2021;20(1):219-221.
   Google Scholar
• Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute thyroiditis associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539.
   PubMed Web of Science ®Google Scholar
• Mattar SAM, Koh SJQ, Rama Chandran S, et al. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8):e237336.
   PubMedGoogle Scholar
• Ruano R, Zorzano-Martinez M, Campos A, et al. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr 2020 S2530–0164(20)30206–8 https://doi.org/10.1016/j.endinu.2020.09.002
   Web of Science ®Google Scholar
• Brancatella A, Ricci D, Cappellani D, et al. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. 2020;105(10):dga a537.
   Web of Science ®Google Scholar
• Mdj SJ, Florencio MQV, Joven MH. Subacute thyroiditis in a patient with coronavirus disease 2019. AACE Clin Case Rep. 2020;6(6):e361–e364.
   PubMedGoogle Scholar
• Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 Infection: a case report and review of literature. Eur Thyroid J. 2021;9(6):324–328.
   PubMed Web of Science ®Google Scholar
• Sohrabpour S, Heidari F, Karimi E, et al. Subacute thyroiditis in COVID-19 patients. Eur Thyroid J. 2021;9(6):321–323.
   PubMed Web of Science ®Google Scholar
• Chakraborty U, Ghosh S, Chandra A, et al. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020;13(12):e239953.
   PubMedGoogle Scholar
• Dworakowska D, Morley S, Mulholland N, et al. Covid-19 related thyroiditis: a novel disease entity? Clin Endocrinol (Oxf). 2021. https://doi.org/10.1111/cen.14453.
   Google Scholar
• Lania A, Sandri MT, Cellini M, et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381–387.
   PubMed Web of Science ®Google Scholar
• Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739–741.
   PubMed Web of Science ®Google Scholar
• Lui DTW, Lee CH, Chow WS, et al. Thyroid with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926–e935.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Arijit S, Sirsendu S, et al. Thyroid function test in COVID-19 patients: a cross-sectional study in a tertiary care hospital. Indian J Endocrinol Metab. 2020;24(6):532–536.
   PubMedGoogle Scholar
• Khoo B, Tan T, Clarke SA, et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab. 2021;106(2):e803–e811.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2021;31(1):8–11.
   PubMed Web of Science ®Google Scholar
• Campi I, Bulgarelli I, Dubini A, et al. The spectrum of thyroid function tests during hospitalization for SARS CoV-2 infection. Eur J Endocrinol. 2021;184(5):EJE-20-1391.R3.
   PubMed Web of Science ®Google Scholar
• Chang L, Yan Y, Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transf Med Rev. 2020(34):75–80.
   PubMedGoogle Scholar
• Rotondi M, Coperchini F, Ricci G, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44(5):1085–1090.
   Google Scholar
• Yao XH, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411–417.
   PubMedGoogle Scholar
• Hanley B, Naresh K, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe Published. 2020;1(6):e245–e253.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun S, Xu CH, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95–102.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Brogioni S, Grasso L, et al. Interleukin-6 and the thyroid. Eur J Endocrinol. 1995;132(4):386–393.
   PubMed Web of Science ®Google Scholar
• Dhakal BP, Sweitzer NK, Indik JH, et al. SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart. Heart Lung Circ. 2020;29(7):973–987.
   PubMed Web of Science ®Google Scholar
• Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–840.
   PubMed Web of Science ®Google Scholar
• Nishihara E, Amino N, Kudo T, et al. Moderate frequency of anti-thyroglobulin antibodies in the early phase of subacute thyroiditis. Eur Thyroid J. 2019;8(5):268–272.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.
   PubMed Web of Science ®Google Scholar
• Zulfiqar AA, Lorenzo-Villalba N, Hassler P, et al. Immune Thrombocytopenic Purpura in a Patient with Covid-19. N Engl J Med. 2020;382(18):e43.
   PubMed Web of Science ®Google Scholar
• Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190(1):29–31.
   PubMed Web of Science ®Google Scholar
• Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576.
   PubMed Web of Science ®Google Scholar
• Anaya JM, Monsalve DM, Rojas M, et al. Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19. J Transl Autoimmun. 2021;4:100091.
   PubMedGoogle Scholar
• Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest. 2001;108(8):1097–1104.
   PubMed Web of Science ®Google Scholar
• Aristo V, Elroy V, Datis K. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2021;19:11: 617089.
   Google Scholar
• Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci USA. 2020;117(41):25254–25262.
   PubMedGoogle Scholar
• Zhang Q, Bastard P, Liu Z, et al., Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 370(6515): eabd 4570. 2020. .
   Web of Science ®Google Scholar
• Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd 4585.
   Web of Science ®Google Scholar
• Cañas CA. The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med Hypotheses. 2020;145:110345.
   PubMed Web of Science ®Google Scholar
• Tee LY, Harjanto S, Rosario BH. COVID-19 complicated by Hashimoto’s thyroiditis. Singapore Med J. 2020. DOI:https://doi.org/10.11622/smedj.2020106
   Web of Science ®Google Scholar
• Mizuno S, Inaba H, Kobayashi KI, et al. A case of postpartum thyroiditis following SARS-CoV-2 infection. Endocr J. 2021; 68(3):371-374.
   Google Scholar
• Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527–1528.
   PubMed Web of Science ®Google Scholar
• Harris A, Al Mushref M. Graves’ thyrotoxicosis following SARS-CoV-2 infection. AACE Clin Case Rep. 2021;7(1):14–16.
   PubMedGoogle Scholar
• Jiménez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: a cause of recurrent Graves’ hyperthyroidism? J Endocrinol Invest. 2021;44(2):387–388.
   PubMed Web of Science ®Google Scholar
• Pastor S, Sr MÁ, De Celis E. Thyrotoxic crisis and COVID-19 infection: an extraordinary case and literature review. Cureus. 2020;12(11):e11305.
   PubMed Web of Science ®Google Scholar
• Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471–474.
   PubMed Web of Science ®Google Scholar
• Murtas R, Andreano A, Gervasi F, et al. Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case-control and population case-control design. Auto Immun Highlights. 2020;11(1):15.
   PubMed Web of Science ®Google Scholar
• Lagadinou M, Zareifopoulos N, Karela A, et al. Are patients with autoimmune disease at greater risk of developing severe COVID-19? J Clin Med Res. 2020;12(8):539–541.
   PubMedGoogle Scholar
• Hariyanto TI, Kurniawan A. Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1429–1430.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin F, Tu W, et al. Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19. Mol Cell Endocrinol. 2021;521:111097.
   PubMed Web of Science ®Google Scholar
• Giovanella L, Ruggeri RM, Ovčariček PP, et al. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021; 1–8. https://doi.org/10.1007/s40336-021-00419-y.
   Web of Science ®Google Scholar
• Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44(5):1031-1040.
   Google Scholar